|
| 36112425 | Lineage switching of the cellular distribution of BRAFV600E in multisystem Langerhans cell histiocytosis. | Blood Adv | 2023 |
| 37236162 | Current clinical practices and challenges in molecular testing: a GOAL Consortium Hematopathology Working Group report. | Blood Adv | 2023 |
| 36503149 | Assessments of Somatic Variant Classification Using the Association for Molecular Pathology/American Society of Clinical Oncology/College of American Pathologists Guidelines: A Report from the Association for Molecular Pathology. | J Mol Diagn | 2023 |
| 36244574 | Recommendations for the Use of in Silico Approaches for Next-Generation Sequencing Bioinformatic Pipeline Validation: A Joint Report of the Association for Molecular Pathology, Association for Pathology Informatics, and College of American Pathologists. | J Mol Diagn | 2023 |
| 34531524 | Molecular characterization of pleomorphic mesothelioma: a multi-institutional study. | Mod Pathol | 2022 |
| 36150820 | Principles and Validation of Bioinformatics Pipeline for Cancer Next-Generation Sequencing. | Clin Lab Med | 2022 |
| 36205930 | Identifying metastatic renal cell carcinoma in thyroid fine-needle aspirates by molecular testing. | Endocr Relat Cancer | 2022 |
| 36063163 | Standards for the classification of pathogenicity of somatic variants in cancer (oncogenicity): Joint recommendations of Clinical Genome Resource (ClinGen), Cancer Genomics Consortium (CGC), and Variant Interpretation for Cancer Consortium (VICC). | Genet Med | 2022 |
| 35101336 | Standards for the classification of pathogenicity of somatic variants in cancer (oncogenicity): Joint recommendations of Clinical Genome Resource (ClinGen), Cancer Genomics Consortium (CGC), and Variant Interpretation for Cancer Consortium (VICC). | Genet Med | 2022 |
| 35189355 | Containers in Bioinformatics: Applications, Practical Considerations, and Best Practices in Molecular Pathology. | J Mol Diagn | 2022 |
| 34727172 | ALK-positive histiocytosis: a new clinicopathologic spectrum highlighting neurologic involvement and responses to ALK inhibition. | Blood | 2022 |
| 34656760 | Electronic Health Records and Genomics: Perspectives from the Association for Molecular Pathology Electronic Health Record (EHR) Interoperability for Clinical Genomics Data Working Group. | J Mol Diagn | 2022 |
| 32354607 | An institutional experience evaluating hTERT immunostaining in 100 consecutive ThinPrep urine specimens. | J Am Soc Cytopathol | 2021 |
| 33644301 | The Ethics of Artificial Intelligence in Pathology and Laboratory Medicine: Principles and Practice. | Acad Pathol | 2021 |
| 33728425 | The Utility of Next-Generation Sequencing in Advanced Breast and Gynecologic Cancers. | Am J Clin Pathol | 2021 |
| 32483596 | Is Next-Generation Sequencing Alone Sufficient to Reliably Diagnose Gliomas? | J Neuropathol Exp Neurol | 2020 |
| 32932212 | Whole exome sequencing reveals BAP1 somatic abnormalities in mesothelioma in situ. | Lung Cancer | 2020 |
| 32376853 | KRAS amplification in metastatic colon cancer is associated with a history of inflammatory bowel disease and may confer resistance to anti-EGFR therapy. | Mod Pathol | 2020 |
| 30648929 | GLIS Rearrangement is a Genomic Hallmark of Hyalinizing Trabecular Tumor of the Thyroid Gland. | Thyroid | 2019 |
| 31298284 | Clinical Utility of GlioSeq Next-Generation Sequencing Test in Pediatric and Young Adult Patients With Brain Tumors. | J Neuropathol Exp Neurol | 2019 |
| 31382034 | Interactive Browser-Based Genomics Data Visualization Tools for Translational and Clinical Laboratory Applications. | J Mol Diagn | 2019 |
| 30836094 | Real-Time Targeted Genome Profile Analysis of Pancreatic Ductal Adenocarcinomas Identifies Genetic Alterations That Might Be Targeted With Existing Drugs or Used as Biomarkers. | Gastroenterology | 2019 |
| 29219616 | Next-Generation Sequencing Approach to Non-Small Cell Lung Carcinoma Yields More Actionable Alterations. | Arch Pathol Lab Med | 2018 |
| 29936258 | Clinical Implementation and Validation of Automated Human Genome Variation Society (HGVS) Nomenclature System for Next-Generation Sequencing-Based Assays for Cancer. | J Mol Diagn | 2018 |
| 29489023 | KRAS mutation is predictive of outcome in patients with pulmonary sarcomatoid carcinoma. | Histopathology | 2018 |
| 29486199 | Loss of Chromatin-Remodeling Proteins and/or CDKN2A Associates With Metastasis of Pancreatic Neuroendocrine Tumors and Reduced Patient Survival Times. | Gastroenterology | 2018 |
| 29154853 | Standards and Guidelines for Validating Next-Generation Sequencing Bioinformatics Pipelines: A Joint Recommendation of the Association for Molecular Pathology and the College of American Pathologists. | J Mol Diagn | 2018 |
| 29249244 | Authors' Reply. | J Mol Diagn | 2018 |
| 27993330 | Standards and Guidelines for the Interpretation and Reporting of Sequence Variants in Cancer: A Joint Consensus Recommendation of the Association for Molecular Pathology, American Society of Clinical Oncology, and College of American Pathologists. | J Mol Diagn | 2017 |
| 28315672 | Principles and Recommendations for Standardizing the Use of the Next-Generation Sequencing Variant File in Clinical Settings. | J Mol Diagn | 2017 |
| 28548125 | Next-generation sequencing-based molecular characterization of primary urinary bladder adenocarcinoma. | Mod Pathol | 2017 |
| 27741389 | Cytohistologic correlation of recurrent urothelial carcinoma detected in urinary diversion specimens. | Cancer Cytopathol | 2017 |
| 27918649 | Big data from small samples: Informatics of next-generation sequencing in cytopathology. | Cancer Cytopathol | 2017 |
| 26901284 | Next-Generation Sequencing Informatics: Challenges and Strategies for Implementation in a Clinical Environment. | Arch Pathol Lab Med | 2016 |
| 26536169 | Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma. | N Engl J Med | 2016 |
| 27471996 | Molecular digital pathology: progress and potential of exchanging molecular data. | Expert Rev Mol Diagn | 2016 |
| 26681766 | Targeted next-generation sequencing panel (GlioSeq) provides comprehensive genetic profiling of central nervous system tumors. | Neuro Oncol | 2016 |
| 26851665 | Molecular Pathology Informatics. | Clin Lab Med | 2016 |
| 25723113 | Molecular characterization of apocrine salivary duct carcinoma. | Am J Surg Pathol | 2015 |
| 26415891 | Validation and utilization of a TFE3 break-apart FISH assay for Xp11.2 translocation renal cell carcinoma and alveolar soft part sarcoma. | Diagn Pathol | 2015 |
| 26065793 | Molecular Pathology Informatics. | Surg Pathol Clin | 2015 |
| 24220144 | SeqReporter: automating next-generation sequencing result interpretation and reporting workflow in a clinical laboratory. | J Mol Diagn | 2014 |
| 25191623 | Smartphone adapters for digital photomicrography. | J Pathol Inform | 2014 |
| 25215253 | Renal medullary carcinoma: case report of an aggressive malignancy with near-complete response to dose-dense methotrexate, vinblastine, Doxorubicin, and Cisplatin chemotherapy. | Case Rep Oncol Med | 2014 |
| 23054954 | Spindle cell carcinoma of the larynx with rhabdomyoblastic heterologous element: a rare form of divergent differentiation. | Head Neck Pathol | 2013 |
| 24225843 | Amylase α-1A (AMY1A): a novel immunohistochemical marker to differentiate chromophobe renal cell carcinoma from benign oncocytoma. | Am J Surg Pathol | 2013 |
| 23955455 | Frozen section diagnosis: is there discordance between what pathologists say and what surgeons hear? | Am J Clin Pathol | 2013 |
| 23979959 | Targeted next-generation sequencing panel (ThyroSeq) for detection of mutations in thyroid cancer. | J Clin Endocrinol Metab | 2013 |
| 22456871 | A novel case of concurrent renal tumors: chromophobe renal cell carcinoma and carcinoid tumor of the kidney with brief review of renal neuroendocrine tumors. | Int J Surg Pathol | 2012 |
| 23121893 | Primary bladder adenocarcinoma versus metastatic colorectal adenocarcinoma: a persisting diagnostic challenge. | Diagn Pathol | 2012 |